Thursday, March 28, 2019 2:55:02 PM
I agree. Since the directors received restricted shares this year already, we're at roughly an OS of 19M shares. Even with the shares they'll receive during the next two years, the OS will only be 20M which is extremely tiny especially in OTC land. Definitely very shares to be had which is why I have been slowly accumulating before news hits and the masses run over each other to buy a few thousand shares. If the sprout thing is connected to JFIL, there may very well be a business plan already in place with some revenue on the horizon. It's a waiting game at this point.
Recent JFIL News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/13/2026 06:22:30 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/24/2025 04:19:45 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 07/10/2025 01:36:57 AM
